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Abstract
Purpose To derive lobar ventilation in patients with chronic obstructive pulmonary disease (COPD) using a rapid time-series
hyperpolarized xenon-129 (HPX)magnetic resonance imaging (MRI) technique and compare this to ventilation/perfusion single-
photon emission computed tomography (V/Q-SPECT), correlating the results with high-resolution computed tomography (CT)
and pulmonary function tests (PFTs).
Materials and methods Twelve COPD subjects (GOLD stages I–IV) participated in this study and underwent HPX-MRI, V/Q-
SPECT/CT, high-resolution CT, and PFTs. HPX-MRI was performed using a novel time-series spiral k-space sampling approach.
Relative percentage ventilations were calculated for individual lobe for comparison to the relative SPECT lobar ventilation and
perfusion. The absolute HPX-MRI percentage ventilation in each lobe was compared to the absolute CT percentage emphysema
score calculated using a signal threshold method. Pearson’s correlation and linear regression tests were performed to compare
each imaging modality.
Results Strong correlations were found between the relative lobar percentage ventilation with HPX-MRI and percentage
ventilation SPECT (r = 0.644; p < 0.001) and percentage perfusion SPECT (r = 0.767; p < 0.001). The absolute CT percentage
emphysema and HPX percentage ventilation correlation was also statistically significant (r = 0.695, p < 0.001). The whole lung
HPX percentage ventilation correlated with the PFT measurements (FEV1 with r = − 0.886, p < 0.001*, and FEV1/FVC with
r = − 0.861, p < 0.001*) better than the whole lung CT percentage emphysema score (FEV1 with r = − 0.635, p = 0.027; and
FEV1/FVC with r = − 0.652, p = 0.021).
Conclusion Lobar ventilation with HPX-MRI showed a strong correlation with lobar ventilation and perfusion measurements
derived from SPECT/CT, and is better than the emphysema score obtained with high-resolution CT.
Key Points
• The ventilation hyperpolarized xenon-129 MRI correlates well with ventilation and perfusion with SPECT/CT with the
advantage of higher temporal and spatial resolution.
• The hyperpolarized xenon-129 MRI correlates with the PFT measurements better than the high-resolution CT with the
advantage of avoiding the use of ionizing radiation.
Keywords Magnetic resonance imaging(MRI) .Single-photonemissioncomputedtomography(SPECT) .Emphysema .Chronic
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Abbreviations
129Xe Xenon-129
3He Helium-3
99mTc-DTPA Technetium-99m
diethylene-triamine-pentaacetate
COPD Chronic obstructive pulmonary disease
CT Computed tomography
FEV1 Forced expiratory volume in 1 s
FVC Forced vital capacity
HP Hyperpolarized
HPX Hyperpolarized 129Xe
LLL Left lower lobe
LUL Left upper lobe
MRI Magnetic resonance imaging
PFT Pulmonary function test
Q-SPECT Perfusion SPECT
RLL Right lower lobe
RML Right middle lobe
RUL Right upper lobe
SPECT Single-photon emission CT
T1 The longitudinal decay time constant
V-SPECT Ventilation SPECT
α Flip angle
Introduction
Chronic obstructive pulmonary disease (COPD), character-
ized by airflow limitation and parenchymal destruction (em-
physema), is currently the fourth leading cause of death world-
wide, and its incidence is predicted to increase in the future [1,
2]. The conventional method of assessment of lung function in
COPD is performed by using pulmonary function tests, pro-
viding an overall measure of lung function but providing lim-
ited information about regional or lobar function. The hetero-
geneous nature of COPD means that accurate and detailed
information on regional structural and functional abnormali-
ties are required to better characterize disease severity and
enable improved choice of potential therapy, for example,
lung volume reduction surgery or endobronchial valves [3].
These targeted regional therapies require robust and detailed
functional and structural imaging both to support patient se-
lection and to determine therapeutic response.
High-resolution computed tomography (CT) is widely
used to assess lung structure in COPD [4, 5]. Lung parenchy-
mal attenuation has been correlated with emphysema and pul-
monary function test (PFT) measurements. Ventilation/
perfusion single-photon emission CT (V/Q-SPECT/CT) has
also been used to assess ventilation and perfusion in COPD
[6–10]. In clinical practice, V/Q-SPECT has been shown to be
a useful imaging technique in the detection of severe ventila-
tion defects in patients with COPD [11]. Its relatively low
spatial and temporal resolution may affect the accuracy of
ventilation defects measured with V-SPECT [12, 13], and
the radiation exposure may be a limiting factor in its use as a
tool in the investigation and follow-up of patients with COPD
[14, 15].
Over the last decade, the advent of non-ionizing
hyperpolarized (HP) gas, i.e., 3He and 129Xe, magnetic reso-
nance imaging (MRI), has shown considerable promise in the
detection of regional ventilation defects in patients with
COPD [16–20]. Although HP 3He exhibits intrinsically stron-
ger MRI signal than HP 129Xe, the use of naturally abundant
129Xe is increasing due to its increased availability, lower cost,
and its additional ability to be used to produce an imaging
measure of gas transfer [21–23]. Conventional proton MRI
of lungs, using oxygen, has also been reported to be a prom-
ising approach for ventilation and perfusion imaging [24];
however, it is limited by its inherent very low signal-to-noise
ratio in the lungs [25].
Combining the increased sensitivity of HP gas MRI in the
detection of ventilation defects with the high spatial resolution
of thoracic CT has been reported to provide accurate quanti-
fication of lobar-specific lung ventilation [3, 26–29].
However, lobar gas ventilation measurements are not possible
using CT as this only provides information about lung struc-
ture and not ventilation. Previously, Stavngaard et al com-
pared HP 3He MRI to 81mKr ventilation scintigraphy using a
visual scoring method and showed that the large ventilation
defects correlated between the two imaging modalities in
healthy patients and a COPD cohort [30]. Stavngaard et al
reported two main limitations in his comparison of HP 3He
MRI and 81mKr ventilation scintigraphy: (i) HP 3He MRI sig-
nal was influenced by the decay of magnetization and (ii) the
comparison was performed using whole lung ventilation and
HP 3He MRI. Although HP gas MRI has been shown to be
sensitive in the detection of ventilation defects, the HP gas
MRI signal may be influenced by multiple factors related to
the gas hyperpolarization level and the decay of HP gas mag-
netization as a function of the number of RF pulses, flip angle
(α), longitudinal decay time constant of hyperpolarization
(T1), imaging hardware, and/or the MR sequence (i.e.,
k-space sampling) [31]. Recently, the development of rapid
HPX-MRI imaging techniques has enabled the acquisition of
time-series images in a single imaging session, in turn
allowing measurement and/or correction of α and T1 varia-
tions [32, 33]. Using a rapid spiral k-space MRI approach,
time-series images can be obtained in a single breath-hold
interval allowing the measurement of α and T1 enabling the
correction of the factors that may influence the HP gas MRI
signal.
The objective of this study was to derive accurate lobar
ventilation measurements using a rapid time-series HPX-
MRI technique correcting the α and T1 variations, in a cohort
of patients with COPD, and to compare them to lobar lung
percentage emphysema scores measured using high-
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resolution CT, lobar lung ventilation/perfusion scores mea-
sured using technetium-99m diethylene-triamine-
pentaacetate (99mTc-DTPA) V/Q-SPECT, and lung function
parameters from PFTs.
Methods
Subject enrollment
The study was approved by the National Research Ethics
Service Committee, and written informed consent was obtained
from all patients (REC approval number: 11/SC/0488). The
cohort consisted of 12 patients with COPD (GOLD stages I
to IV). Subject demographics, FEV1 (%Pred), and FEV1/FVC
measurements from PFTs are detailed in Table 1. Male (n = 4)
and female (n = 8) subjects enrolled had average ages of 65.6 ±
5.0 and 61.5 ± 10.8. The patients were scanned using three
imaging modalities including high-resolution CT, time-series
HPX-MRI, proton MRI, V/Q-SPECT, and anatomical low-
dose CT images. All the scans and PFTs were performed on
the same day. PFTs were performed according to ATS/ERS
guidelines.
High-resolution CT
Thin-slice (0.625 mm) CT images were acquired (Discovery
670; GE Healthcare) 60 s post-administration of 100 mL of
intravenous iohexol contrast (equivalent to 300 mg of organic
iodine per mL), administered as part of our approved research
protocol, with the following CT parameters: FOV of 50 cm,
current 50–400 smart mA, voltage of 120 kV, tube collimation
of 1.25 mm, and beam pitch of 0.938:1. Images were acquired
after inspiration of air in the supine position. The high-
resolution CT images were used to delineate the three lobes
in the right lung (i.e., right upper lobe (RUL), right middle
lobe (RML), and right lower lobe (RLL)) and two lobes in the
left lung (i.e., left upper lobe (LUL), left lower lobe (LLL)).
The absolute CT-%emphysema score for each lobe was cal-
culated using dedicated open-access software (Pulmonary
Toolkit, PTK, version 3) representing the ratio of number of
pixels less than the signal threshold of – 950 HU to the total
number of pixels in each lobe as previously described [3]. The
percentage CT emphysema was calculated using the equation
below:
%Emphysema ¼ npixel=VLobe
  100
where npixel is the number of pixels less than the signal thresh-
old of – 950 HU and VLobe is the volume of lobe.
V/Q-SPECT/CT
SPECT and low-dose CT images were acquired using a GE
Discovery 670 SPECT/CTscanner according to local standard
protocols. Ventilation SPECT images were acquired using
500 MBq technetium-99m diethylene-triamine-pentaacetate
(99mTc-DTPA), LEHR collimators, 64 × 64 matrix size, 20 s
per projection with aerosol produced by a SmartVent™ deliv-
ery system (Diagnostic Imaging Ltd., Welford, UK).
Perfusion SPECT/CT images were then acquired, low energy,
high-resolution (LEHR) collimators, 128 × 128 matrix size,
30 s per projection. This SPECT/CT system has a SPECT
spatial resolution of ~ 10 mm, with ~ 4 mm pixel size for a
128 × 128 matrix size. SPECT images were reconstructed
using the accompanied low-dose CT for attenuation correction
with commercially available software (Xeleris 3, GE
Healthcare, Milwaukee, USA). SPECT/CT lobar lung venti-
lation and perfusion were calculated using semi-automated
software (Hermes Lung Lobar Analysis version 2, Hermes
Medical Solutions AB, Stockholm, Sweden) by an experi-
enced radiologist (M.C.). The relative percentage ventilation/
perfusion (i.e., relative SPECT-%ventilation and relative
SPECT-%perfusion) represented the ratio of sum of signal in
each lobe and volume of whole lung from low-dose CT im-
ages assuming that the sum of the lobar percentages will add
up to 100%. Therefore, the absolute CT-%emphysema score
was conceptually different to the relative SPECT-%perfusion
and relative SPECT-%ventilation although they are both ex-
pected to correlate with the ventilation defects of COPD. The
percentage lobar ventilation and perfusion were calculated
using the equation below:
%Ventilation ¼ Slobe=V lung
  100
where Slobe is the sum of signal in a lobe and Vlung is the
volume of the whole lung.
Table 1 Subject demographics and lung function test
Subject
number
Sex
(male/female)
Age
(years)
GOLD
stage
FEV1
(% predicted)
FEV1/
FVC (%)
1 Female 72 II 61 70
2 Male 67 III 41 49
3 Male 65 III 46 51
4 Female 58 II 57 68
5 Male 64 III 46 51
6 Male 73 IV 25 37
7 Male 62 II 63 63
8 Male 58 II 47 57
9 Male 64 II 63 75
10 Male 72 II 61 70
11 Female 68 III 30 47
12 Female 48 I 74 68
M ± SD 64 ± 7 51 ± 14 59 ± 12
FEV1, forced expiratory volume in 1 s; FVC, forced vital capacity
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Proton MRI
Anatomical proton MR images were acquired on a 1.5-T MR
scanner (Signa HDx, GEHC, Milwaukee, WI) using the fol-
lowing scanning parameters: field of view 40× 40 cm2, band-
width 125 kHz, TE/TR 2.8 ms/1.2 ms, matrix 128 × 128, slice
thickness 15 mm; 13 slices were acquired from posterior to
anterior in the coronal plane and a single slice in axial and
sagittal planes.
HPX-MRI
Imaging was performed using 1-L bags of HP-enriched xe-
non gas (87% 129Xe) polarized to 10–15% using a commer-
cially available polarizer (Model 9300, Polarean, Durham,
NC). Time-series HPX images were acquired in the coronal
plane using 13 slices with a slice thickness of 15 mm and
field of view of 32 cm and constructed with an image matrix
size of 128 × 128. Time-series HPX-MRI involved the acqui-
sition of 8 sets of volume images in a single ~ 20-s breath-
hold using 8-interleave spiral k-space sampling leading a time
delay of ~ 2.5 s for each volume image (i.e., temporal reso-
lution of ~ 2.5 s) and the pixel resolution of 2.5 mm (spatial
resolution 2–3 mm) [32]. The time-series HPX-MRI allowed
the calculation of the relative percentage ventilation (i.e., rel-
ative HPX-%ventilation) similar to the concept of SPECT
relat ive perfusion and vent i la t ion (i .e . , re la t ive
SPECT-%perfusion and relative SPECT-%ventilation).
Additionally, the absolute percentage ventilation (i.e., the ab-
solute HPX-%ventilation) similar to the absolute
CT-%emphysema score was calculated using a signal thresh-
old method in each lung lobe.
The lobar lung masks obtained from the CT images
were co-registered to proton MRI anatomical images and
HPX-MRI for calculation of lobar ventilation using previ-
ously described open-source software (ITK-SNAP) [34].
Thereafter, the registered lung lobar masks applied to the
HPX time-series images yielding the HPX signal time
curves was performed using MATLAB. The HPX signal
time curves were then fitted by the HP signal loss equa-
tions for calculation and correction of flip angle (α) and
the longitudinal HP signal decay time (T1), as explained
in Supplementary Material 1 [32]. The effects of flip angle
variations on the signal dynamics and image intensity are
also explained in Supplementary Material 2.
The relative HPX-%ventilation
The percentage lobar lung ventilation relative to the whole
lung volume was calculated for comparison to the relative
SPECT-%ventilation and SPECT-%perfusion. The relative
HPX-%ventilation was calculated as the ratio of the sum
of signal in each lobe and volume of whole lung from the
high-resolution CT images assuming that the sum of the
lobar percentages will also add up to 100% similar to the
relative SPECT-%ventilation.
The absolute HPX-%ventilation
For comparison with absolute CT-%emphysema scores, the per-
centage ventilation defects were measured using a signal thresh-
old method previously used for similar comparison between HP
3He MRI and CT-%emphysema score [27]. The HPX signal
threshold was defined as 5% of the HPX signal measured across
the whole lungs. The absolute HPX-%ventilation score was cal-
culated as the ratio of the number of pixels below the signal
threshold to the total number of pixels.
Statistical analysis
All statistical tests were performed using GraphPad Prism
(version 7.00, GraphPad Software, CA, USA). The absolute
CT-%emphysema, relative HPX-%ventilation, and relative
V/Q-SPECT/CT scores were compared using Pearson’s cor-
relation with a confidence interval of 95% to investigate any
significant differences. Linear regression analysis was also
used to investigate the relationship between the imaging mo-
dalities for lobar measurements across the entire subject pop-
ulation. FEV1 (%Pred) and FEV1/FVC measured using PFTs
were also compared to the whole lung absolute
CT-%emphysema score and the absolute HPX-%ventilation
for each subject.
Results
Twelve subjects with a mean FEV1 (%Pred) = 51 ± 14 and
FEV1/FVC (%) = 59 ± 12 as shown in Table 1 were success-
fully scanned using HPX-MRI and CT. The first subject was
not scanned with V/Q-SPECT/CT and the second subject was
not scanned with Q-SPECT.
Representative coronal slices from CT images including the
emphysema map, protonMRI, HPX-MRI, and V/Q-SPECT/CT
of a severe COPD subject (stages III and IV, subjects 3 and 6 in
Table 1) are shown in Fig. 1a–d, respectively. The high percent-
age areas of emphysema (> 20%) are indicated with yellow lines
on the CT in both lower lobes as shown in Fig. 1a with lung
parenchyma of low attenuation (< − 950 HU) highlighted in col-
or. Areas of CT emphysema in both lower lobes are in visual
agreement with the regions of low ventilation on HPX-MRI in
Fig. 1b and regions of low ventilation and perfusion on V/Q-
SPECT/CT in Fig. 1c, d.
The lobar CT, HPX-MRI, and V/Q-SPECT/CT measure-
ments from two COPD subjects with GOLD stage IV are
shown in Fig. 2a, c individually. The CT-%emphysema scores
were 29% and 25% in the RLL and LLL and were greater than
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in the RUL = 15%, RML = 18%, and LUL = 18%. The high
CT-%emphysema in the lower lobes of the lungs corresponded
to conspicuous ventilation defects on HPX-MRI with the rela-
tive HPX-%ventilation of the RLL = 9% and LLL = 13%, in
the V-SPECT images with the relative SPECT-%ventilation of
the RLL = 5% and LLL = 6%, and in the Q-SPECT images
with the relative SPECT-%perfusion of the RLL = 8% and
LLL = 8%. Similarly, another COPD subject GOLD stage IV
with a high CT-%emphysema was also inversely correlated to
the relative HPX-%ventilation (Pearson’s correlation: r =
− 0.856, p < 0.05*), SPECT-%ventilation (Pearson’s correla-
tion: r = − 0.822, p < 0.05*), and SPECT-%perfusion
(Pearson’s correlation: r = − 0.828 and p < 0.05*) in Fig. 2c.
Although the inversely proportional results were statistically
significant in severe COPD subjects (GOLD stage IV), there
was a poor correlation between the absolute CT-%emphysema
and the relative lobar measurement scores in two COPD sub-
jects (GOLD stage II) in Fig. 2b, d, individually.
The linear regression of lobar measurements in all COPD
subjects is shown between the absolute CT-%emphysema and
the relative HPX-%ventilation, the absolute HPX-%ventilation,
SPECT-%perfusion, and SPECT-%ventilation in Fig. 3a–d, re-
spectively. The linear slopes were negative between
CT-%emphysema score and the relative HPX-%ventilation
(slope = − 0.36 ± 0.15, p = 0.02*; r = − 0.313, p = 0.015*), the
absolute HPX-%ventilation (slope = 1.84 ± 0.15, p < 0.01*;
r = 0.701, p < 0.0001*), SPECT-%perfusion (slope = − 0.38 ±
0 . 1 5 , p = 0 . 0 1 * ; r = − 0 . 3 74 , p = 0 . 0 0 7* ) , a n d
SPECT-%ventilation (slope = − 0.28 ± 0.11, p = 0.02*; r =
− 0.319, p = 0.017*).
The relative measurements from HPX-MRI and V/Q-
SPECT/CT are compared in Fig. 4. The correlations were r =
0.767, r = 0.644, and r = 0.884 with p < 0.001 between the rel-
ative HPX-%ventilation and SPECT-%perfusion, between the
relative HPX-%ventilation and SPECT-%ventilation, and be-
tween the SPECT-%ventilation and SPECT-%perfusion in
Fig. 4a–c, respectively.
Figure 5 demonstrates the comparison between PFT
measurements FEV1 (%Pred) and FEV1/FVC (%) with
whole lung absolute HPX-%ventilation in Fig. 5a, b and
absolute CT-%emphysema in Fig. 5c, d. There was a sta-
tistically significant correlation between HPX-%ventilation
and FEV1 (%Pred) and between HPX-%ventilation and
FEV1/FVC (%) with r = − 0.886 and r = − 0.861 with
p < 0.001 in Fig. 5a, b suggesting a stronger correlation
and then CT-%emphysema and FEV1 (%Pred) and
CT-%emphysema and FEV1/FVC (%) with r = − 0.635
with p = 0.027 and r = − 0.652 with p = 0.021.
Fig. 1 a The high-resolution CT
images of a stage IV COPD
(subject 3 in Table 1) patient for
selected five slices in coronal
plane including the measured
emphysema values are shown.
Yellow lines indicate the regions
with high emphysema. b Proton
MRI and HPX-MRI images of a
stage IV COPD patient (subject 3
in Table 1) for selected five slices
in coronal plane are shown. c, d
V/Q-SPECT and low-dose CT
fused images of a stage IV COPD
patient (subject 3 in Table 1) for
selected five slices in coronal
plane are shown. Yellow lines
indicate the regions with severe
emphysema
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Fig. 2 The measured absolute
CT-%emphysema, the relative
HPX-%ventilation and SPECT-
%ventilation, and SPECT-
%perfusion are shown in two
severe COPD (stage III and stage
IV) (a, c) and two mild COPD
(stage IV) (b, d) for each lobe.
RUL, right upper lobe; RML,
right middle lobe; RLL, right
lower lobe; LUM, left upper lobe;
LLL, left lower lobe
Fig. 3 The linear regression of
the lobar scores between the
absolute CT-%emphysema and
the relative HPX-%ventilation,
the absolute HPX-%ventilation,
SPECT-%perfusion, and SPECT-
%ventilation are shown in a–d
over the entire COPD patient
population including the liner
regression lines, slope, and
p values
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Discussion
The relative and absolute lobar percentage ventilation defects
obtained using a time-series HPX-MRI technique have been
compared systematically to (i) the relative lobar ventilation
and perfusion scores measured using V/Q-SPECT/CT, (ii)
the absolute lobar emphysema score measured using high-
resolution CT, and (iii) lung function (i.e., FEV1 (%Pred) and
FEV1/FVC) in a COPD cohort. The study findings suggest
that there is a very strong correlation between the lobar lung
measurements of relative percentage ventilations between the
time-series HPX-MRI and V/Q-SPECT/CT. Additionally,
time-series HPX-MRI allowed measurement of absolute per-
centage ventilation of whole lung and correlates with FEV1
(%Pred) and FEV1/FVC measurements better than CT in a
COPD cohort with GOLD stages I–IV. Compared to V/Q-
SPECT/CT, the time-series HPX-MRI presents a promising
non-ionizing technique for longitudinal assessment of
COPD, because of its very high temporal resolution (2.5 s)
and spatial resolution (2–3 mm) and as it may be employed
repeatedly and only takes a few minutes to perform.
The HPX gas signal intensity directly correlates to ventila-
tion in the lung airspaces; however, it may be influenced by
other factors including the choice of k-space sampling, RF
coil performance and design (i.e., surface or volume coils),
and magnetic field strength [32, 35, 36]. The flip angle pro-
files can significantly vary over the entire imaging volume
particularly for the surface RF coils as shown in
Supplementary Fig. 2 resulting in variation in the signal inten-
sities of up to a factor of 2 between the anterior and posterior
Fig. 5 The relation of the whole
lung scores between the absolute
HPX-%ventilation and CT-
%emphysema and FEV1 (%Pred)
and FEV1/FVC are shown in a–d
including the liner regression
lines, slope, and p values
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Fig. 4 The linear regressions of the relative lobar scores between SPECT-%perfusion and HPX-%ventilation (a), between SPECT-%ventilation and
HPX-%ventilation (b), and between SPECT-%ventilation and SPECT-%perfusion (c) are shown including the liner regression lines, slope, and p values
regions of the RUL and LUL of the lung. Despite the HPX-
MRI being acquired with a spiral k-space sampling approach
using eight interleaves with relatively lower spatial resolution
(pixel resolution of 2.5 mm) than the previously used
Cartesian k-space sampling method (pixel resolution of
~ 2 mm) [3], the temporal resolution with the proposed tech-
nique in this study was higher by a factor of ~ 5 than the
previously reported Cartesian k-space sampling method. The
use of the time-series HPX-MRI technique can further im-
prove the assessment of ventilation defects by eliminating
the RF coil flip angle variations allowing relative and absolute
measurements of ventilation defects. Eight time steps were
used in this study for estimating the flip angle and T1, allowed
a very high goodness-of-fit (R-squared > 0.98), as shown in
the supplementary materials. In theory, using three time steps
would be sufficient for solving the three unknowns as ex-
plained in the supplementary material. Although all the pa-
tients in our study were able to tolerate a 20-s breath-hold to
enable eight time step scanning, the required number of im-
ages (i.e., time steps) can be reduced for the patients who are
unable to manage a breath-hold interval of 20 s. Conceptually,
the spatial resolution would be further increased by using less
time steps and a higher number of interleaves depending on
the clinical information and sensitivity required.
The negative correlat ion between the relat ive
HPX-%ventilation and CT-%emphysema is consistent with pre-
vious findings reported by Matin et al [3] in a COPD cohort. As
expected, the trend of correlation between HPX-%ventilation
and CT-%emphysema depended on the method of
HPX-%ventilation calculation (i.e., relative or absolute). There
was a significant linear correlation between absolute
HPX-%ventilation and CT-%emphysema, similar to a previous
HP 3He study by Tahir et al [27, 37]. Despite the statistical
corre la t ion between CT-%emphysema score and
HPX-%ventilation score, the intrinsic variations between the
two imaging modalities are likely due to the sensitivity of (i)
HPX to airway blockages, mucus plugs, and collapse of airways
and (ii) CT’s structural assessment of the lungs as discussed
previously [28, 38–40].
Although the correlation between CT and HP gas (129Xe and
3He) has been reportedwidely, this is the first study to our knowl-
edge comparing lobar ventilation defects from HPX-MRI to
V/Q-SPECT/CT. Stavngaard et al investigated large ventilation
defects in COPD subjects using a visual (i.e., subjective) scoring
factor and showed a good correlation between HP 3He gas MRI
and regional 81mKr gas ventilation scintigraphy. However, the
objective computational comparison between HP 3He gas MRI
and 81mKr ventilation scintigraphy showed a relatively low cor-
relation (r = 0.45, p = 0.016). Although there is an expected dif-
ference in diffusion between aerosol radiotracers (i.e., 81mKr) and
gas radiotracers (99mTc-DTPA) or HP 129Xe gas, the measured
relative lobar ventilation measures correlated better in our study
between HPX-MRI and 99mTc-DTPAV/Q-SPECT/CT.
As expected, HPX-MRI provided significantly higher
spatial resolution and temporal resolution than V/Q-
SPECT/CT. Additionally, there is image blurring in V/Q-
SPECT compared to HPX-MRI images, due to motion
artifact, because SPECT is performed as the patient
breathes normally and the images are acquired over 30
to 40 min. In this respect, the ventilation defects identified
on SPECT scans correspond to stationary ventilation de-
fects that have stabilized after many inhalation cycles,
making it insensitive to the time course of ventilation
dynamics. However, HPX-MRI can capture the dynamics
of xenon gas ventilation during the wash-in, breath-hold,
and washout cycles separately enabling correlation with
different physiological information (i.e., delayed ventila-
tion) as discussed previously [32]. Nonetheless, the lobar
lung analysis of the V/Q-SPECT images provided suffi-
cient resolution, to confirm that the lobar ventilation and
perfusion were comparable to HPX-MRI, although pixel
by pixel analysis of ventilation defects may reveal greater
differences between the two imaging modalities. At pres-
ent a significant limitation when considering the value of
HPX-MRI to SPECT/CT is that HPX-MRI is not yet in
widespread use as a routine clinical imaging technique,
although the body of evidence to support its use is
increasing.
Although our CT scans were performed using intravenous
contrast as part of our approved research protocol, calculating
emphysema scores in patient with COPD does not require con-
trast [41]. As well as enabling emphysema scores to be calculat-
ed, it is also possible to calculate bronchial wall thickness and air
flow restriction using novel CT techniques [42–44].
Although the uneven distribution of Technegas be-
tween V-SPECT and Q-SPECT is to be expected as pre-
viously reported by Bajc et al [11], the agreement between
the V-SPECT and Q-SPECT measurements was greater
than the agreement between HPX-MRI and V/Q-SPECT/
CT. This may be because the lobar ventilation and perfu-
sion scores in SPECT were performed using the low-dose
CT data acquired in the same imaging session as the V-
SPECT and Q-SPECT, potentially enabling better co-
registration, whereas the lobar ventilation analysis of
HPX-MRI requires image co-registration to CT performed
at a different time to the HPX-MRI and is likely to be less
accurate. Even though the lungs are deformable, ITK-
SNAP was able to register HPX-MRI images to CT using
manual segmentation, and in the future, the increased spa-
tial resolution of conventional proton MRI may enable
improved lobar segmentation, which will significantly im-
prove the lobar analysis of HPX-MRI ventilation defects.
Although in comparison, the dedicated automated soft-
ware used for V-SPECT and Q-SPECT co-registration
and analysis may also provide more accurate image data
analysis. It is also important to highlight that the regional
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(i.e., pixel by pixel) comparisons from the anterior to the
posterior parts of the lungs may show a larger variation
with HPX-MRI than with V/Q-SPECT/CT due to differ-
ences in both the imaging processing, and the temporal
and spatial resolution, and need further investigation. As
such, this study raises additional questions about which
imaging modality would be more sensitive to early-stage
COPD when using pixel by pixel comparison of mild
ventilation defects in patients with GOLD stages I–II.
Conclusion
We have successfully demonstrated the measurement of abso-
lute and relative percentage lobar ventilation using a novel
time-series HPX-MRI sequence that corrects for intrinsic
MR parameters in a small cohort of patients with COPD.
This time-series HPX-MRI approach has been validated
through comparison with V/Q SPECT/CT and high-
resolution CT. Relative lobar ventilation measured by time-
series HPX-MRI correlated statistically with relative percent-
age lobar perfusion and ventilation scores obtained with V/Q-
SPECT/CT. Furthermore, a strong agreement between the ab-
solute lobar ventilation from time-series HPX-MRI and the
absolute lobar CT percentage emphysema score has been
shown. Finally, the correlation between whole lung HPX-
MRI and PFTs including FEV1 (%Pred) and FEV1/FVC was
stronger than the whole lung CT emphysema score.
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